-
effectivehealthcare.ahrq.gov/health-topics/hodgkin-disease
-
effectivehealthcare.ahrq.gov/health-topics/bells-palsy
-
effectivehealthcare.ahrq.gov/health-topics/chiari-malformation
-
effectivehealthcare.ahrq.gov/health-topics/foodborne-illness
-
effectivehealthcare.ahrq.gov/products/n-1-trials/research-2014-1
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/transitions-care-pediatric-to-adult-services-disposition-comments.pdf
May 31, 2022 - training or education, transition workbook or
toolkit, EMR transition tool, summer program,
music therapy … Educational materials
about survivor care and late effects of cancer
therapy are also available for … cancer population due to the unique,
complex, and long term health care needs
resulting from cancer treatment … lived with developmental delays
their entire life versus one who acquired a
development delay after treatment … Examples include various non-pharmacological
treatments, behavioral interventions, lifestyle
modifications
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/worker-health_research-protocol.pdf
May 26, 2015 - , method of
handling dropouts and missing data, validity and reliability of outcome measures, and
treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
July 01, 2012 - stratification will depend to a large extent on clearer
evidence that surveillance, diagnostic, and treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_research-protocol.pdf
January 13, 2014 - healthpolicybrief_65.pdf
Joy M, Little E, Maruthur N, Purnell T, Bridges J (2013) Patient preferences for the
treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-eligible-disabled_research.pdf
June 01, 2011 - Methodological issues in the case of
administrative claims data to study surveillance after cancer treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
October 01, 2007 - By contrast, PharmaCare’s official evidence-
review agency, the Therapeutics Initiative in the Department … of Pharmacology and Therapeutics at University of British
Columbia, concluded that neither the long-term … Periodic letters on evidence-
based drug therapy improves prescribing: a randomized trial. … Clinical and economic
consequences of a reimbursement restriction of nebulised respiratory
therapy in … study of neuroleptics: can between-physician dif-
ferences in prescribing patterns be used to estimate treatment
-
effectivehealthcare.ahrq.gov/health-topics/wilson-disease
-
effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address
-
effectivehealthcare.ahrq.gov/products/health-data-mapping/protocol
-
effectivehealthcare.ahrq.gov/health-topics/pelvic-support-problems
-
effectivehealthcare.ahrq.gov/health-topics/kidney-cysts
-
effectivehealthcare.ahrq.gov/products/breast-reconstruction-mastectomy/protocol
-
effectivehealthcare.ahrq.gov/products/depression-brain-injury/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
October 01, 2016 - follow-
up, the pooled effect size for behavioral measurements
was significant in favor of placebo treatment … RCTs where no significant
differences in outcomes were observed between
intervention and placebo treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/child-obesity-future_research.pdf
March 31, 2010 - We received one set of comments from the American Therapy
Association (APTA). … Intervention Model: Parallel
Assignment
Masking: Single Blind (Outcomes
Assessor)
Primary Purpose: Treatment … Classification: Efficacy
Study
Intervention Model: Parallel
Assignment
Masking: Open Label
Primary Purpose: Treatment